We are live on ! Find out more
ECP

Empyrean Capital Partners Portfolio holdings

AUM $3.07B
1-Year Est. Return 34.24%
This Fund
S&P 500
This Quarter Est. Return
+18.67%
1 Year Est. Return
+34.24%
3 Year Est. Return
+104.05%
5 Year Est. Return
+133.06%
10 Year Est. Return
+500.1%
AUM
$3.16B
AUM Growth
+$1.29B
Cap. Flow
+$905M
Cap. Flow %
28.69%
Top 10 Hldgs %
54.05%
Holding
89
New
25
Increased
13
Reduced
14
Closed
10

Sector Composition

Rank Sector Weight
1 Financials 14.66%
2 Technology 8.15%
3 Communication Services 7.48%
4 Healthcare 6.5%
5 Real Estate 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$701M 22.21%
+2,584,100
New +$698M
DVA icon
2
CALL
DaVita
DVA
$15.5B
$166M 5.27%
+2,394,400
New +$160M
TLT icon
3
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$42.4B
$144M 4.57%
+1,185,200
New +$142M
AET
4
DELISTED
Aetna Inc
AET
$139M 4.42%
+759,600
New +$135M
NXPI icon
5
NXP Semiconductors
NXPI
$60.8B
$126M 3.98%
1,150,000
+282,312
+33% +$31.1M
TFCF
6
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$99.7M 3.16%
+2,023,442
New +$79.1M
TFCFA
7
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$86.2M 2.73%
1,735,267
-323,000
-16% -$12.8M
SHPG
8
DELISTED
Shire pic
SHPG
$86.2M 2.73%
+510,410
New +$82.3M
SRG
9
Seritage Growth Properties
SRG
$138M
$84.2M 2.67%
1,983,614
+180,000
+10% +$7.03M
DELL icon
10
Dell
DELL
$239B
$73.1M 2.32%
3,079,425
-509,550
-14% -$11.3M
PFE icon
11
Pfizer
PFE
$143B
$68M 2.16%
1,976,250
-974,950
-33% -$33.3M
IWM icon
12
PUT
iShares Russell 2000 ETF
IWM
$79.1B
$60.8M 1.93%
371,200
-865,800
-70% -$139M
EQH icon
13
Equitable Holdings
EQH
$13.2B
$59.8M 1.9%
+2,902,190
New +$61.8M
ENVA icon
14
Enova International
ENVA
$6.09B
$54.8M 1.74%
1,499,221
-599,000
-29% -$18.2M
ISBC
15
DELISTED
Investors Bancorp, Inc.
ISBC
$53.7M 1.7%
4,200,000
CURO
16
DELISTED
CURO Group Holdings Corp.
CURO
$53M 1.68%
2,125,540
+601,740
+39% +$13.2M
DD icon
17
DuPont de Nemours
DD
$18.6B
$52.7M 1.67%
315,905
BIIB icon
18
Biogen
BIIB
$30.9B
$51M 1.62%
175,859
+25,859
+17% +$7.27M
LTRPA
19
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$49M 1.55%
3,046,032
-50,000
-2% -$648K
PLYA
20
DELISTED
Playa Hotels & Resorts
PLYA
$44.8M 1.42%
4,151,604
+1,369,309
+49% +$14.6M
LADR
21
Ladder Capital
LADR
$1.24B
$44.8M 1.42%
2,865,636
-830,776
-22% -$12.5M
PRSU
22
Pursuit Attractions and Hospitality Inc
PRSU
$1.45B
$42.4M 1.34%
781,273
+60,387
+8% +$3.22M
LSXMK
23
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$39.8M 1.26%
1,151,493
TLT icon
24
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$42.4B
$36.6M 1.16%
+300,800
New +$36M
GSAH.U
25
DELISTED
GS Acquisition Holdings Corp. Units, each consisting of one share of Class A common stock and one-th
GSAH.U
$35.8M 1.13%
+3,500,000
New +$35.8M

Similar funds

Empyrean Capital Partners's Q2 2018 Portfolio in Review

As of Q2 2018, Empyrean Capital Partners held 89 positions worth $3.16B, up 69% from $1.87B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Empyrean Capital Partners deployed $905M of net new capital in Q2 2018, opening 25 new positions and adding to 13 existing holdings. Its largest new stake was Aetna Inc: 759,600 shares worth $139M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 11% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Pfizer, an estimated $33.3M trimmed.

  • Empyrean Capital Partners's largest Q2 2018 buy was Aetna Inc: 759,600 shares worth $139M.
  • Empyrean Capital Partners added most to NXP Semiconductors in Q2 2018, an estimated $31.1M increase.
  • Empyrean Capital Partners's biggest Q2 2018 reduction was Pfizer, cutting an estimated $33.3M.
  • Empyrean Capital Partners fully exited Time Warner Inc in Q2 2018, selling an estimated $182M.
  • Empyrean Capital Partners's ten largest holdings make up 54% of its $3.16B portfolio in Q2 2018.
  • Empyrean Capital Partners opened 25 new positions and closed 10 in Q2 2018.
  • Empyrean Capital Partners's portfolio value rose 69% quarter-over-quarter to $3.16B.

Based on Empyrean Capital Partners's 13F filing for Q2 2018, filed 14 Aug 2018.